Understanding non-falciparum malaria and its transmission
Emergents International Centers of Excellence for Malaria Research
This study is looking at two types of malaria that are often ignored, to help find better ways to diagnose and understand how they spread, especially in children under 11 in Central Africa, where malaria is a big health concern.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Florida NIH-funded |
| Lab location | 1 site (Gainesville, United States) |
| Project ID | NIH-11077835 on NIH RePORTER |
What this research studies
This research focuses on non-falciparum malaria, specifically the parasites P. ovale and P. malariae, which are often overlooked in malaria studies. By using advanced genomic techniques, the project aims to accurately diagnose these infections, quantify their presence in the population, and assess how they are transmitted by mosquitoes. The research will also evaluate the resistance of these mosquitoes to insecticides, which is crucial for developing effective control strategies. This work is particularly important for children under 11 years old in Central Africa, where malaria remains a significant health threat.
Who could benefit from this research
Good fit: Ideal candidates for this research are children aged 0-11 years living in Central Africa who may be infected with non-falciparum malaria.
Not a fit: Patients outside the age range of 0-11 years or those not residing in Central Africa may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnosis and treatment strategies for non-falciparum malaria, ultimately reducing the disease burden in affected populations.
How similar studies have performed: While research on P. falciparum malaria is extensive, studies focusing on non-falciparum malaria are less common, making this approach relatively novel.
Where this research is happening
Gainesville, United States
- University of Florida — Gainesville, United States (Active)
Researchers
- Principal investigator: Dinglasan, Rhoel David Ramos — University of Florida
- Study coordinator: Dinglasan, Rhoel David Ramos
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.